Spineology has received US Food and Drug Administration (FDA ) clearance for its new Rampart line of Interbody fusion implants.

The interbody fusion system is incorporated with implantation equipment designed to enhance a surgeon’s ability to position the implant within the disc space.

The Rampart line will feature a variety of implant configurations, lengths and heights providing the surgeon with several options to fit patient needs.

The company is committed to increasing procedural efficiency, reducing surgical morbidity and accelerating patient recovery.